RNA Therapeutics, Part B, Volume 204 updates on a new class of medication based on RNA molecules, with chapters on a variety of topics, including RNA therapeutics for cardiovascular disorders, RNA therapeutics for kidney injury, RNA therapeutics for beta-thalassemia, RNA therapeutics for infectious diseases, RNA therapeutics for reproductive diseases, Potential of RNA and transcriptomic data to drive drug repurposing for various diseases, RNA therapeutics for glioma/glioblastoma, RNA therapeutics for regenerative medicine, Advances in the liposome-based delivery systems for RNA therapeutics in cancer, Advances in the polymeric nanoparticulate delivery systems for RNA therapeutics in cancer, and more.
1. Cover image - p. i 2. Title page - p. ii 3. Table of Contents - p. iii 4. Copyright - p. iii 5. Contributors - p. iii 6. Preface - p. iii 7. Chapter One: RNA interference-based therapies for atherosclerosis: Recent advances and future prospects - p. 1 8. Chapter Two: An update on the therapeutic role of RNAi in NAFLD/NASH - p. 45 9. Chapter Three: RNA therapeutics for kidney injury - p. 69 10. Chapter Four: RNA therapeutics for β-thalassemia - p. 97 11. Chapter Five: RNA therapeutics for infectious diseases - p. 109 12. Chapter Six: Application of RNA-based therapeutics in glioma: A review - p. 134 13. Chapter Seven: RNA therapeutics for regenerative medicine - p. 163 14. Chapter Eight: Advances in liposome-based delivery of RNA therapeutics for cancer treatment - p. 177 15. Chapter Nine: Advances in the polymeric nanoparticulate delivery systems for RNA therapeutics - p. 219 16. Chapter Ten: Advances in RNA therapeutics for modulation of ‘undruggable’ targets - p. 249 17. Chapter Eleven: RNA therapeutics for diarrhea - p. 295 18. Chapter Twelve: Biosafety and regulatory issues of RNA therapeutics - p. 311 19. Index - p. 329
RNA Therapeutics, Part B, Volume 204 updates on a new class of medication based on RNA molecules, with chapters on a variety of topics, including RNA therapeutics for cardiovascular disorders, RNA therapeutics for kidney injury, RNA therapeutics for beta-thalassemia, RNA therapeutics for infectious diseases, RNA therapeutics for reproductive diseases, Potential of RNA and transcriptomic data to drive drug repurposing for various diseases, RNA therapeutics for glioma/glioblastoma, RNA therapeutics for regenerative medicine, Advances in the liposome-based delivery systems for RNA therapeutics in cancer, Advances in the polymeric nanoparticulate delivery systems for RNA therapeutics in cancer, and more.
1. Cover image - p. i 2. Title page - p. ii 3. Table of Contents - p. iii 4. Copyright - p. iii 5. Contributors - p. iii 6. Preface - p. iii 7. Chapter One: RNA interference-based therapies for atherosclerosis: Recent advances and future prospects - p. 1 8. Chapter Two: An update on the therapeutic role of RNAi in NAFLD/NASH - p. 45 9. Chapter Three: RNA therapeutics for kidney injury - p. 69 10. Chapter Four: RNA therapeutics for β-thalassemia - p. 97 11. Chapter Five: RNA therapeutics for infectious diseases - p. 109 12. Chapter Six: Application of RNA-based therapeutics in glioma: A review - p. 134 13. Chapter Seven: RNA therapeutics for regenerative medicine - p. 163 14. Chapter Eight: Advances in liposome-based delivery of RNA therapeutics for cancer treatment - p. 177 15. Chapter Nine: Advances in the polymeric nanoparticulate delivery systems for RNA therapeutics - p. 219 16. Chapter Ten: Advances in RNA therapeutics for modulation of ‘undruggable’ targets - p. 249 17. Chapter Eleven: RNA therapeutics for diarrhea - p. 295 18. Chapter Twelve: Biosafety and regulatory issues of RNA therapeutics - p. 311 19. Index - p. 329
